rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)

Clinical trial NCT00053573 · COMPLETED

Trial details

NCT number: NCT00053573
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II Pompe Disease Acid Maltase Deficiency Disease Glycogenosis 2

Start date: 2003-02-01
Primary completion: 2006-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.